ORIYOMI OMOTOYOSI AKINYOTU

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 marketed ·

Quick facts

Marketed products

Sulphadoxine-Pyrimethamine · Infectious Disease
Sulphadoxine-pyrimethamine inhibits dihydrofolate reductase and dihydropteroate synthase in parasites, blocking folate synthesis and DNA replication.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

ORIYOMI OMOTOYOSI AKINYOTU portfolio CI brief
ORIYOMI OMOTOYOSI AKINYOTU pipeline updates RSS

Frequently asked questions about ORIYOMI OMOTOYOSI AKINYOTU

What are ORIYOMI OMOTOYOSI AKINYOTU's marketed drugs?

Top marketed products include Sulphadoxine-Pyrimethamine.

Sulphadoxine-Pyrimethamine · Infectious Disease
Sector hub: All tracked pharma companies